Inventory / revenue moved 223 bp lower
Inventory / revenue changed -223 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
64.18%→61.95%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →DE financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income increased 7.0%
Net income changed +7.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$1.3B→$1.4B3 prior comparisons
Revenue increased 4.9%
Revenue changed +4.9% from the comparable as-filed period.
$12.0B→$12.6B3 prior comparisons
Cash & equivalents increased 4.1%
Cash & equivalents changed +4.1% from the comparable as-filed period.
$8.6B→$8.9B2 prior comparisons
Research & development increased 2.0%
Research & development changed +2.0% from the comparable as-filed period.
$556.0M→$567.0M3 prior comparisons
Inventory increased 1.3%
Inventory changed +1.3% from the comparable as-filed period.
$7.7B→$7.8B3 prior comparisons
Selling, general & administrative increased 0.2%
Selling, general & administrative changed +0.2% from the comparable as-filed period.
$1.2B→$1.2B3 prior comparisons
Revenue increased 4.7%
Revenue changed +4.7% from the comparable as-filed period.
$12.8B→$13.4B0 prior comparisons
Selling, general & administrative increased 1.0%
Selling, general & administrative changed +1.0% from the comparable as-filed period.
$1.2B→$1.2B0 prior comparisons
Net income decreased 1.7%
Net income changed -1.7% from the comparable as-filed period.
$1.8B→$1.8B0 prior comparisons
Cash & equivalents decreased 1.1%
Cash & equivalents changed -1.1% from the comparable as-filed period.
$8.0B→$7.9B0 prior comparisons
Research & development increased 6.2%
Research & development changed +6.2% from the comparable as-filed period.
$549.0M→$583.0M0 prior comparisons
Inventory increased 4.0%
Inventory changed +4.0% from the comparable as-filed period.
$7.9B→$8.2B0 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.